MT
Healthcare & Life Sciences
Memo Therapeutics
Switzerlandmemo-therapeutics.com
Memo Therapeutics is a Healthcare & Life Sciences startup based in Switzerland, since acquired.
Acquiredacquired
acquired
Stage
About Memo Therapeutics
Based in Switzerland, Memo Therapeutics is a startup. Memo Therapeutics has been acquired. Brouky classifies it under Healthcare & Life Sciences.
Memo Therapeutics is a late-stage biotech company developing therapeutic antibodies based on natural human immunity, with a lead program potravitug in Phase II clinical trials targeting BK polyomavirus infection in kidney transplant recipients, and also working on antibody discovery for cancer treatment.
Explore Memo Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.